Novel distribution of the secretory leucocyte proteinase inhibitor in kidney

The secretory leucocyte proteinase inhibitor (SLPI) is a low molecular weight, tissue-specific inhibitor of, for example, elastase and cathepsin G, which also have antimicrobial capacity. SLPI has been localised to the respiratory, gastrointestinal and genital tracts, but so far not to the kidney. T...

Full description

Saved in:
Bibliographic Details
Main Authors: Sophie Ohlsson, Irena Ljungkrantz, Kjell Ohlsson, Mårten Segelmark, Jörgen Wieslander
Format: Article
Language:English
Published: Wiley 2001-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1080/09629350120102389
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The secretory leucocyte proteinase inhibitor (SLPI) is a low molecular weight, tissue-specific inhibitor of, for example, elastase and cathepsin G, which also have antimicrobial capacity. SLPI has been localised to the respiratory, gastrointestinal and genital tracts, but so far not to the kidney. The presence of SLPI in renal tubuli cells was demonstrated using immunohistochemistry and, by means of in situ hybridisation on human renal biopsies, we were able to demonstrate SLPI production. In various inflammatory conditions in the kidneys, the protease-antiprotease balance is disturbed. For this reason, as well as the possible role in the defence against ascending urinary tract infections, it is interesting to establish a source of SLPI in renal tubuli cells.
ISSN:0962-9351
1466-1861